Company news

Cogstate Ltd news in 2016

Cogstate Ltd's news releases, calls and decks from 2016, newest first.

View company

Cogstate enters into agreement with Clinical Ink

October 25, 2016

2016 Financial Year Results

August 17, 2016

Chairmans Address to Shareholders

March 30, 2016

JV Agreement Signed

March 30, 2016

CogState 2010 AGM Address

March 30, 2016

NRL mandates use of CogState for concussion management

March 30, 2016

Growth in sales contracts delivers strong Q1 results

March 30, 2016

CogState Tests Used in Successful Ph 2 Schizophrenia Study

March 30, 2016

CogState announces partnership in area of cognitive training

March 30, 2016

CogState Again Used in Successful Schizophrenia Study

March 30, 2016

Business Update - Unaudited Full Year Profit Results

March 30, 2016

CogState signs sales contract for phase 3 study

March 30, 2016

CogState signs sales contract for phase 2 study

March 30, 2016

CogState signs sales contract for large phase 2 study

March 30, 2016

CogState Signs Contract For Phase 2 Schizophrenia Study

March 30, 2016

CogState partners with Merck Canada

March 30, 2016

Merck releases new data on effectiveness of Cognigram

March 30, 2016

Growing recognition of Cogstate test as a cognitive tool

March 30, 2016

CogState launches Cognigram test in Canada

March 30, 2016

Fully Underwritten Non-Renounceable Rights Issue / Placement

March 30, 2016

Business Update and First Half Financial Guidance

March 30, 2016

30 Sep 2013 Business Update and Appendix 4C

March 30, 2016

Precision Recruitment chosen for phase III Alzheimers study

March 30, 2016

Contracts signed since 1 July 2014 hit $9 million

March 30, 2016

Cogstate Test to be used in large paediatric clinical trial

March 30, 2016

Cogstate signs first client to Precision Recruitment

March 30, 2016

Cogstate signs $7.3 million sales contract

March 30, 2016

Cogstate provides update on sales contracts

March 30, 2016

Business update and guidance on FY14 results

March 30, 2016

Cogstate enters into Letter of Intent for sale of Axon Sport

March 30, 2016

Cogstate signs US$2m sales contract

March 17, 2016

Appendix 4C - quarterly (amended)

February 11, 2016

Sales Contract Update

February 10, 2016

Sales contract update

February 10, 2016

Rights Issue Offer Document

February 10, 2016

Quarterly Business Update and Cashflow - 30 June 2013

February 10, 2016

Proposed Issue of Unlisted Options

February 10, 2016

Preliminary Final Report and Annual Report

February 10, 2016

Preliminary Final Report

February 10, 2016

Non-Executive Director Appointment and Private Placement

February 10, 2016

Launch of Axon Sports

February 10, 2016

FY15 Half Year Results Guidance

February 10, 2016

CogState tests helping to detect Alzheimers disease

February 10, 2016

Cogstate Test Provides Better Assessment than Observation

February 10, 2016

Cogstate technology chosen for major Phase III trial

February 10, 2016

Cogstate signs US$4.9m sales contract

February 10, 2016

Cogstate signs US$3.1M sales contract extension

February 10, 2016

Cogstate signs sales contract for Phase 3 Oncology trial

February 10, 2016

Cogstate signs sales contract for Alzheimers Disease trial

February 10, 2016

Cogstate selected for Alzheimers disease preventation trial

February 10, 2016

Older news releases →

Decks in 2016